Joaquin Duato is a globally experienced, values-driven healthcare business leader and currently Vice Chairman of the Executive Committee of Johnson & Johnson, the world’s premier healthcare company. Joaquin is responsible for the company’s Pharmaceuticals and Consumer sectors, as well as Supply Chain, Information Technology, Global Services, and the Health and Wellness groups. He is a respected industry leader and is the immediate past chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Joaquin played an instrumental role in leading the turnaround of the Johnson & Johnson Pharmaceuticals sector. A 28-year veteran of the company, Joaquin was named Company Group Chairman of the Americas in 2009. He then continued leading the global transformation upon his appointment to his most recent role as Executive Vice President and Worldwide Chairman, Pharmaceuticals in 2011. During that time, the sector grew into what is today the fourth-largest innovative pharmaceutical company globally. The results are clear: With 17 new products launched since 2011 and up to 10 potential billion-dollar medicines expected to be launched and/or filed before 2021, the Johnson & Johnson Pharmaceuticals sector is poised to extend its track record of seven years of above-market growth.
As a dual citizen of Spain and the United States with extensive experience living and working on the ground on multiple continents, Joaquin brings a unique international perspective to his work. His global experience has given him an appreciation for the value of diversity of thought and opinions, which he brings to bear externally as a member of the Tsinghua University SPS Advisory Board, and internally as the executive sponsor of the African American Leadership Council. His commitment to nurturing a culture of diversity was recognized in 2017 by the Healthcare Businesswomen’s Association (HBA) when he was named 2017 Honorable Mentor.
Joaquin also has a passion for learning, with an undergraduate degree in economics and business, a Master of Business Administration (MBA) degree from ESADE Business School in Barcelona, Spain, and a Master of International Management degree from Thunderbird in Phoenix, Arizona. He is a champion of improving access to both health literacy and education more broadly and recently completed his term as board member of the international charity Save the Children. In addition, he mentors MBA candidates at universities around the world and speaks regularly on leadership in pharmaceuticals at industry forums and academic institutions.